In non-small cell lung cancer and colorectal cancer, PGE2 enhances β-catenin nuclear localization and inhibits GSK3β by phosphorylation which is dependent on cAMP and kinase activity of PKA [34,36]. Here, GSK3B is linked to colorectal cancer.